We've arrived at ACS Boston!The conference is already well and truly underway, kicking off with streams focusing on emerging trends in target identification, small molecule treatments for inflammatory bowel disease and 'DNA, RNA and Inorganic Drugs'.
Highlights include a talk by Justin Jeff Wilson (Cornell University, NY, USA), who presented novel research on rhenium as an alternative to platinum for the treatment of cancer, and Robin Bevernaegie (Université catholique de Louvain, Ottignies-Louvain-la-Neuve, Belgium) discussing the theranostic applications of highly photo reactive Ir(III) complexes.
Are you getting ready for #ACSBoston? Don't forget to come to the MedChemNet booth #512 to #spinthewheel! pic.twitter.com/hUB7ZAFIpU
@sirfrasersays : “people, not money, are the key to scientific breakthroughs” #ACSBoston
|Today's featured guest|
|Freya Leask, RegMedNet (London, UK)|
|Picture of the Day||Tomorrow's key talk|
|Confronting the Opioid Epidemic: Novel Treatments for Chronic Pain|
|We're all set up here at ACS Boston! Come meet us at booth #512.||Room 210B, Boston Convention and Exhibition Center|
|Today's news highlights|
|Light-activated oxygen could kill antibiotic-resistant bacteria|
|Research presented at the 256th National Meeting of the American Chemical Society suggests treatment-resistant MRSA could be targeted by light-activated oxygen.|